Project Grant R33HL175683

Award Date 9/6/24
Completion Date 7/31/26
Dollars Obligated $959K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Hadley, MA 01035, USA
Similar Awards
This National Science Foundation (NSF) Engineering (CFDA 47.041) program grant, in the amount of $400,000, supports the development of a tissue-like, converged sensing platform for tracking excitation-contraction dynamics in cardiac organoids. The project aims to: Develop a scalable assembly strategy to fabricate an array of three-dimensional sensor structures using planar semiconducting graphene material, designed to detect both electrical and mechanical stimuli. Evaluate the multifunctional...
This $599,486 National Science Foundation award under the Engineering (47.041) program will fund the development of an engineered cardiac tissue model with embedded soft microelectronics for continuous cardiotoxicity screening at The Pennsylvania State University from January 2022 to September 2023. The key product is a 3D-bioprinted, microvascularized cardiac tissue model integrated with stretchable microelectronics to enable real-time, intra-tissue measurement of cardiotoxicity responses to...
This federal Project Grant award, valued at $127,926 and awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a real-time, continuous monitoring platform to track cardiac biomarkers (cTnI and NT-proBNP) alongside ECG readings. This platform, which integrates a 3D-printed, flexible subdermal biochemical sensor with an external wearable...
This Project Grant award from the National Institute of Environmental Health Sciences (CFDA 93.113 - Environmental Health) to Neurolux Inc. aims to commercialize an Electromechanically Monitored Engineered Heart Tissue (EMEHT) platform developed at Northwestern University. The $525,824 award will support developing a consumable electronics fabrication process and custom data acquisition/bioamplification equipment for the EMEHT platform. This will enable wider dissemination and use of the...
This Project Grant award from the National Science Foundation (NSF) under the Engineering program (CFDA 47.041) provides $199,992 to Boston University to develop a high-throughput electrical stimulation screening platform for assessing the long-term effects of cardiac contractility modulation (CCM) devices on engineered human heart tissue. The project will support a postdoctoral scholar co-mentored by researchers at the Food and Drug Administration (FDA) and Boston University to advance...
This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) is supporting a collaborative research effort focused on developing an intelligent lab-on-chip device to monitor and promote the maturation of stem cell-derived cardiomyocytes. The $192,150 award to the New York Institute of Technology (NYIT) aims to create an integrated system that can non-invasively evaluate cardiomyocyte maturity in real-time and adaptively apply electrical and mechanical...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA Program 93.837 - Cardiovascular Diseases Research, aims to ameliorate cardiac fibrosis using diverse human cardiac organoid models. The $159,512 award will support research to discover and validate compounds that can combat the activation of cardiac fibroblasts, a key driver of cardiac fibrosis in dilated cardiomyopathy (DCM). The project will utilize 3D induced pluripotent stem cell-derived cardiac...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $275,396 to Link Biosystems Inc., a self-certified small disadvantaged business, to develop bioreactor technologies for efficient differentiation, scale-up, and maturation of induced pluripotent stem cell (iPSC)-derived cardiomyocytes. The research aims to address challenges in producing clinically relevant quantities of...
This $100,000 Project Grant from the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems supports the development of a 3D human stem cell cardiac model for cardiac electrophysiology medical device safety assessment. Funded under the NSF Engineering program (CFDA 47.041), this award will allow the University of Maryland, College Park to create a novel in vitro model for evaluating the safety and efficacy of cardiac medical devices through January...
This federal Project Grant award of $507,000.00 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund the development of an innovative, automated system that integrates micro-electromechanical systems (MEMS) sensor pipettes, automation, and machine vision to simultaneously and directly measure electrophysiological properties and contractile forces in single human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). This system...

FLEXIBLE BIOELECTRONICS PLATFORM CONVERGING CAPILLARY-LIKE DELIVERY NETWORK AND SENSING FEEDBACK NETWORK FOR IMPROVING CARDIAC TISSUE ENGINEERING - PROJECT SUMMARY CARDIAC DISEASES REMAIN THE LEADING CAUSE OF HUMAN MORBIDITY AND MORTALITY. CARDIAC MICROTISSUES/ORGANOIDS BUILT FROM HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES (HIPSC-CMS) PROVIDE PROMISING PLATFORMS FOR DISEASE MODELING AND LONG-TERM TREATMENT (E.G., THROUGH TRANSPLANTATION). HOWEVER, RECAPITULATING THE INTRICATE ENVIRONMENT OF THE HUMAN HEART, ESPECIALLY THE GLOBAL CELL MATURITY, HAS PROVEN CHALLENGING IN VITRO. ONE PRIMARY HURDLE IS THE LACK OF CONSISTENT DELIVERY OF OXYGEN AND NUTRIENTS TO THE DEEP-LAYER TISSUE, LEADING TO UNBALANCED TISSUE DEVELOPMENT THAT EVENTUALLY IMPAIRS THE FULL FUNCTIONAL MATURATION FOR PRECISION STUDIES. EXISTING ARTIFICIAL VASCULAR SYSTEMS ARE EITHER CONFINED TO PLANAR SUBSTRATE OR LIMITED IN RESOLUTION, FALLING SHORT OF THE SPATIAL COVERAGE AND RESOLUTION IN THE CAPILLARY NETWORK OF A LIVING ORGAN FOR EFFICIENT MEDIA DELIVERY. MOREOVER, NO CONCURRENT SENSING NETWORK AND BIOELECTRONIC DATA ANALYTICS ARE AVAILABLE TO PROVIDE REAL-TIME AND COMPREHENSIVE ASSESSMENT (E.G., LINK TO MOLECULAR CELL MECHANISMS) OF THE DELIVERY EFFECT ACROSS THE 3D TISSUE. TO FILL IN THE GAPS, WE AIM TO DEVELOP AN ULTRA-FLEXIBLE AND STRETCHABLE BIOELECTRONIC MICROARCHITECTURE THAT INTEGRATES A CAPILLARY-LIKE NETWORK FOR EFFICIENT MEDIA DELIVERY AND A TISSUE-LIKE SENSING NETWORK FOR TISSUE-STATE FEEDBACK. THE SYSTEM WILL BE SEAMLESSLY INTEGRATED WITH CARDIAC MICROTISSUES TO IMPROVE TISSUE DEVELOPMENT. WE WILL ALSO TRANSLATE THE REAL-TIME PHYSIOLOGICAL FEEDBACK TO MOLECULAR CELL MECHANISMS TO ENABLE COMPREHENSIVE QUANTIFICATION OF THE DELIVERY EFFECT. TO REALIZE THE GOALS, AIM 1 WILL FOCUS ON CONSTRUCTING THE FLEXIBLE BIOELECTRONIC MICROARCHITECTURE, OPTIMIZING THE CONVERGED DELIVERY AND SENSING FUNCTIONS, INTEGRATING THE SYSTEM IN CARDIAC MICROTISSUES, AND EVALUATING THE INTERFACING INTIMACY AND MEDIA DELIVERY EFFICIENCY. AIM 2 WILL FOCUS ON THE COMPREHENSIVE ANALYSIS AND OPTIMIZATION OF DELIVERY EFFECT, THROUGH THE MULTIPLE EFFORTS OF PERFORMING LONG-TERM ELECTRICAL RECORDING, EMPLOYING IN SITU ELECTRO-SEQUENCING TO COMBINE 3D SPATIAL TRANSCRIPTOMICS WITH ELECTRICAL RECORDING, AND USING ANALYTICS TO CONNECT FUNCTIONAL PHENOTYPES TO MOLECULAR CELL MECHANISMS. THE SUCCESS OF THIS WORK WILL PROVIDE A TRANSFORMATIVE PLATFORM FOR IMPROVING CARDIAC TISSUE ENGINEERING. THIS PLATFORM CAN BE READILY TRANSLATED TO OTHER TISSUE SYSTEMS FOR IMPROVING FUNCTION AND DEVELOPMENT.

Posted 9/6/24